Astex Pharmaceuticals (ASTX)
Add to Watchlists Create an Alert
5.36
+0.24 +4.69%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Astex Pharmaceuticals EPS Diluted Quarterly YoY Growth:
-75.00% for Dec. 31, 2012Astex Pharmaceuticals Historical EPS Diluted Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -75.00% |
| Dec. 31, 2012 | 1808% |
| Sept. 30, 2012 | |
| June 30, 2012 | 0.00% |
| March 31, 2012 | -55.56% |
| Dec. 31, 2011 | -97.88% |
| Sept. 30, 2011 | |
| June 30, 2011 | -50.00% |
| March 31, 2011 | 12.50% |
| Dec. 31, 2010 | 177.7% |
| Sept. 30, 2010 | 500.0% |
| June 30, 2010 |
About EPS Growth
YCharts EPS growth rates are calculated as quarterly year on year growth rates.
EPS growth (earnings per share growth) illustrates the growth of earnings per share over time. EPS growth rates help investors identify stocks that are increasing or decreasing in profitability.
If a company has an EPS of $5.00 in 2008 and EPS of $6.00 in 2009, the company has an EPS growth rate of $6.00/$5.00 - 1 = 20% during fiscal year 2009.
Learn More
ASTX EPS Diluted Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| AcelRx Pharmaceuticals | |
| GlaxoSmithKline | -28.21% |
| Rockwell Medical |
ASTX EPS Diluted Quarterly YoY Growth Range, Past 5 Years
| Minimum | -97.88% | Dec 2011 |
| Maximum | 1808% | Dec 2012 |
| Average | 223.4% |
ASTX News
Astex Pharmaceuticals' CEO Presents at UBS Global Healthcare Conference (Transcript)
Seeking Alpha May 20
Seeking Alpha May 20